Annual Revenue
$128.26 M
+$24.99 M+24.20%
26 May 2024
Summary:
Lifecore Biomedical annual revenue is currently $128.26 million, with the most recent change of +$24.99 million (+24.20%) on 26 May 2024. During the last 3 years, it has risen by +$27.39 million (+27.15%). LFCR annual revenue is now -77.00% below its all-time high of $557.56 million, reached on 01 May 2019.LFCR Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$24.70 M
-$13.18 M-34.79%
25 August 2024
Summary:
Lifecore Biomedical quarterly revenue is currently $24.70 million, with the most recent change of -$13.18 million (-34.79%) on 25 August 2024. Over the past year, it has dropped by -$5.45 million (-18.06%). LFCR quarterly revenue is now -84.12% below its all-time high of $155.55 million, reached on 01 February 2019.LFCR Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$128.44 M
+$183.00 K+0.14%
25 August 2024
Summary:
Lifecore Biomedical TTM revenue is currently $128.44 million, with the most recent change of +$183.00 thousand (+0.14%) on 25 August 2024. Over the past year, it has increased by +$16.09 million (+14.32%). LFCR TTM revenue is now -78.22% below its all-time high of $589.64 million, reached on 01 November 2019.LFCR TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LFCR Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.2% | -18.1% | +14.3% |
| 3 y3 years | +27.1% | -43.1% | +23.5% |
| 5 y5 years | -77.0% | -82.7% | -78.2% |
LFCR Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +27.1% | -43.1% | +16.9% | -10.6% | +37.7% |
| 5 y | 5 years | -77.0% | +27.1% | -83.8% | +109.0% | -78.2% | +246.5% |
| alltime | all time | -77.0% | +6007.7% | -84.1% | +109.0% | -78.2% | >+9999.0% |
Lifecore Biomedical Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Aug 2024 | - | $24.70 M(-34.8%) | $128.44 M(+0.1%) |
| May 2024 | $128.26 M(+24.2%) | $37.89 M(+6.1%) | $128.26 M(+5.5%) |
| Feb 2024 | - | $35.70 M(+18.4%) | $121.52 M(+8.2%) |
| Nov 2023 | - | $30.15 M(+23.0%) | $112.35 M(+8.0%) |
| Aug 2023 | - | $24.52 M(-21.3%) | $104.07 M(+0.8%) |
| May 2023 | $103.27 M(-7.2%) | $31.15 M(+17.4%) | $103.27 M(+10.7%) |
| Feb 2023 | - | $26.54 M(+21.4%) | $93.25 M(-10.4%) |
| Nov 2022 | - | $21.86 M(-7.8%) | $104.12 M(-17.2%) |
| Aug 2022 | - | $23.72 M(+12.3%) | $125.70 M(-12.5%) |
| May 2022 | $111.27 M(+10.3%) | $21.13 M(-43.5%) | $143.61 M(+48.5%) |
| Feb 2022 | - | $37.40 M(-13.9%) | $96.73 M(-7.0%) |
| Nov 2021 | - | $43.45 M(+4.4%) | $104.02 M(-45.7%) |
| Aug 2021 | - | $41.63 M(-261.6%) | $191.47 M(-32.9%) |
| May 2021 | $100.87 M(-37.0%) | - | - |
| May 2021 | - | -$25.75 M(-157.6%) | $285.48 M(+670.2%) |
| Feb 2021 | - | $44.69 M(-65.9%) | $37.07 M(-74.5%) |
| Nov 2020 | - | $130.90 M(-3.5%) | $145.31 M(-7.4%) |
| Aug 2020 | - | $135.64 M(-149.5%) | $157.00 M(-1.9%) |
| May 2020 | $160.07 M(-71.3%) | -$274.17 M(-279.3%) | $160.07 M(-72.7%) |
| Feb 2020 | - | $152.93 M(+7.2%) | $587.01 M(-0.4%) |
| Nov 2019 | - | $142.59 M(+2.8%) | $589.64 M(+3.2%) |
| Aug 2019 | - | $138.71 M(-9.2%) | $571.61 M(+2.5%) |
| May 2019 | $557.56 M(+6.4%) | $152.78 M(-1.8%) | $557.56 M(+2.1%) |
| Feb 2019 | - | $155.55 M(+24.9%) | $545.86 M(+2.0%) |
| Nov 2018 | - | $124.56 M(-0.1%) | $535.21 M(+0.4%) |
| Aug 2018 | - | $124.67 M(-11.6%) | $533.11 M(+1.7%) |
| May 2018 | $524.23 M(+11.6%) | $141.08 M(-2.6%) | $524.23 M(+17.0%) |
| Feb 2018 | - | $144.91 M(+18.3%) | $448.10 M(+1.9%) |
| Nov 2017 | - | $122.46 M(+5.8%) | $439.76 M(-3.0%) |
| Aug 2017 | - | $115.78 M(+78.3%) | $453.16 M(-3.5%) |
| May 2017 | $469.78 M(-1.5%) | $64.95 M(-52.4%) | $469.78 M(-1.3%) |
| Feb 2017 | - | $136.57 M(+0.5%) | $475.96 M(+1.4%) |
| Nov 2016 | - | $135.87 M(+2.6%) | $469.38 M(-1.0%) |
| Aug 2016 | - | $132.39 M(+86.1%) | $473.96 M(-0.6%) |
| May 2016 | $476.92 M(-11.6%) | $71.13 M(-45.3%) | $476.92 M(-11.7%) |
| Feb 2016 | - | $129.99 M(-7.4%) | $540.23 M(-1.6%) |
| Nov 2015 | - | $140.44 M(+3.8%) | $548.77 M(+1.4%) |
| Aug 2015 | - | $135.35 M(+0.7%) | $541.00 M(+0.3%) |
| May 2015 | $539.26 M(+13.1%) | $134.45 M(-2.9%) | $539.26 M(+2.6%) |
| Feb 2015 | - | $138.53 M(+4.4%) | $525.74 M(+2.4%) |
| Nov 2014 | - | $132.66 M(-0.7%) | $513.59 M(+2.5%) |
| Aug 2014 | - | $133.61 M(+10.5%) | $500.95 M(+5.1%) |
| May 2014 | $476.81 M(+7.9%) | $120.93 M(-4.3%) | $476.81 M(+3.0%) |
| Feb 2014 | - | $126.38 M(+5.3%) | $463.00 M(+1.9%) |
| Nov 2013 | - | $120.03 M(+9.6%) | $454.49 M(+1.2%) |
| Aug 2013 | - | $109.48 M(+2.2%) | $449.11 M(+1.7%) |
| May 2013 | $441.71 M(+39.1%) | $107.11 M(-9.1%) | $441.71 M(+5.9%) |
| Feb 2013 | - | $117.87 M(+2.8%) | $417.21 M(+10.0%) |
| Nov 2012 | - | $114.65 M(+12.3%) | $379.41 M(+9.6%) |
| Aug 2012 | - | $102.07 M(+23.6%) | $346.32 M(+9.1%) |
| May 2012 | $317.55 M(+14.8%) | $82.62 M(+3.2%) | $317.55 M(+4.8%) |
| Feb 2012 | - | $80.06 M(-1.8%) | $303.03 M(+2.2%) |
| Nov 2011 | - | $81.57 M(+11.3%) | $296.48 M(+4.0%) |
| Aug 2011 | - | $73.30 M(+7.6%) | $285.08 M(+3.0%) |
| May 2011 | $276.73 M(+16.2%) | $68.10 M(-7.4%) | $276.73 M(+3.7%) |
| Feb 2011 | - | $73.51 M(+4.8%) | $266.85 M(+6.1%) |
| Nov 2010 | - | $70.17 M(+8.0%) | $251.47 M(+3.8%) |
| Aug 2010 | - | $64.95 M(+11.6%) | $242.24 M(+1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2010 | $238.22 M(+1.0%) | $58.22 M(+0.1%) | $238.22 M(+2.6%) |
| Feb 2010 | - | $58.13 M(-4.6%) | $232.25 M(+1.9%) |
| Nov 2009 | - | $60.93 M(-0.0%) | $228.02 M(+1.3%) |
| Aug 2009 | - | $60.94 M(+16.7%) | $225.13 M(-4.6%) |
| May 2009 | $235.94 M(-1.1%) | $52.24 M(-3.1%) | $235.94 M(-2.1%) |
| Feb 2009 | - | $53.91 M(-7.1%) | $241.00 M(-2.3%) |
| Nov 2008 | - | $58.04 M(-19.1%) | $246.70 M(-0.4%) |
| Aug 2008 | - | $71.75 M(+25.2%) | $247.62 M(+3.8%) |
| May 2008 | $238.53 M(+13.3%) | $57.30 M(-3.9%) | $238.53 M(+2.6%) |
| Feb 2008 | - | $59.61 M(+1.1%) | $232.43 M(+2.9%) |
| Nov 2007 | - | $58.96 M(-5.9%) | $225.78 M(+1.7%) |
| Aug 2007 | - | $62.66 M(+22.4%) | $222.01 M(+5.5%) |
| May 2007 | $210.50 M(-9.2%) | $51.20 M(-3.3%) | $210.50 M(-8.7%) |
| Feb 2007 | - | $52.95 M(-4.1%) | $230.58 M(-1.8%) |
| Nov 2006 | - | $55.19 M(+7.9%) | $234.88 M(+0.6%) |
| Aug 2006 | - | $51.15 M(-28.3%) | $233.40 M(+0.6%) |
| May 2006 | $231.95 M(+13.0%) | $71.29 M(+24.5%) | $231.95 M(+7.0%) |
| Feb 2006 | - | $57.25 M(+6.6%) | $216.84 M(+2.7%) |
| Nov 2005 | - | $53.71 M(+8.1%) | $211.12 M(+1.5%) |
| Aug 2005 | - | $49.70 M(-11.5%) | $208.08 M(+1.4%) |
| May 2005 | $205.23 M(+6.8%) | $56.17 M(+9.0%) | $205.23 M(-1.1%) |
| Feb 2005 | - | $51.53 M(+1.7%) | $207.49 M(+1.4%) |
| Nov 2004 | - | $50.67 M(+8.1%) | $204.55 M(+3.8%) |
| Aug 2004 | - | $46.85 M(-19.8%) | $197.14 M(+2.6%) |
| May 2004 | $192.09 M(+71.1%) | $58.44 M(+20.3%) | $192.09 M(+0.8%) |
| Feb 2004 | - | $48.59 M(+12.3%) | $190.50 M(+4.1%) |
| Nov 2003 | - | $43.27 M(+3.5%) | $183.04 M(+1.1%) |
| Aug 2003 | - | $41.80 M(-26.5%) | $180.99 M(-1.5%) |
| May 2003 | $112.26 M(-38.7%) | - | - |
| Apr 2003 | - | $56.84 M(+38.2%) | $183.66 M(-0.1%) |
| Jan 2003 | - | $41.13 M(-0.2%) | $183.94 M(+0.4%) |
| Oct 2002 | $183.16 M(-4.0%) | $41.22 M(-7.3%) | $183.16 M(+1.1%) |
| July 2002 | - | $44.47 M(-22.1%) | $181.23 M(-1.4%) |
| Apr 2002 | - | $57.12 M(+41.6%) | $183.81 M(-2.7%) |
| Jan 2002 | - | $40.35 M(+2.7%) | $188.95 M(-3.9%) |
| Oct 2001 | $190.88 M(-3.2%) | $39.29 M(-16.5%) | $196.70 M(-0.8%) |
| July 2001 | - | $47.05 M(-24.4%) | $198.32 M(-6.8%) |
| Apr 2001 | - | $62.26 M(+29.5%) | $212.77 M(+0.7%) |
| Jan 2001 | - | $48.10 M(+17.6%) | $211.37 M(+7.2%) |
| Oct 2000 | $197.16 M(+819.4%) | $40.91 M(-33.5%) | $197.17 M(+33.4%) |
| July 2000 | - | $61.49 M(+1.0%) | $147.81 M(+61.0%) |
| Apr 2000 | - | $60.86 M(+79.5%) | $91.81 M(+83.4%) |
| Jan 2000 | - | $33.90 M(-501.0%) | $50.07 M(+133.2%) |
| Oct 1999 | $21.45 M(-36.0%) | -$8.45 M(-253.7%) | $21.47 M(-38.9%) |
| July 1999 | - | $5.50 M(-71.2%) | $35.13 M(+0.6%) |
| Apr 1999 | - | $19.13 M(+260.9%) | $34.93 M(+3.6%) |
| Jan 1999 | - | $5.30 M(+1.9%) | $33.70 M(+0.6%) |
| Oct 1998 | $33.50 M(+252.6%) | $5.20 M(-1.9%) | $33.50 M(+3.7%) |
| July 1998 | - | $5.30 M(-70.4%) | $32.30 M(+3.2%) |
| Apr 1998 | - | $17.90 M(+251.0%) | $31.30 M(+118.9%) |
| Jan 1998 | - | $5.10 M(+27.5%) | $14.30 M(+49.0%) |
| Oct 1997 | $9.50 M(+352.4%) | $4.00 M(-7.0%) | $9.60 M(+74.5%) |
| July 1997 | - | $4.30 M(+377.8%) | $5.50 M(+223.5%) |
| Apr 1997 | - | $900.00 K(+125.0%) | $1.70 M(-19.0%) |
| Jan 1997 | - | $400.00 K(-500.0%) | $2.10 M(0.0%) |
| Oct 1996 | $2.10 M | -$100.00 K(-120.0%) | $2.10 M(-4.5%) |
| July 1996 | - | $500.00 K(-61.5%) | $2.20 M(+29.4%) |
| Apr 1996 | - | $1.30 M(+225.0%) | $1.70 M(+325.0%) |
| Jan 1996 | - | $400.00 K | $400.00 K |
FAQ
- What is Lifecore Biomedical annual revenue?
- What is the all time high annual revenue for Lifecore Biomedical?
- What is Lifecore Biomedical annual revenue year-on-year change?
- What is Lifecore Biomedical quarterly revenue?
- What is the all time high quarterly revenue for Lifecore Biomedical?
- What is Lifecore Biomedical quarterly revenue year-on-year change?
- What is Lifecore Biomedical TTM revenue?
- What is the all time high TTM revenue for Lifecore Biomedical?
- What is Lifecore Biomedical TTM revenue year-on-year change?
What is Lifecore Biomedical annual revenue?
The current annual revenue of LFCR is $128.26 M
What is the all time high annual revenue for Lifecore Biomedical?
Lifecore Biomedical all-time high annual revenue is $557.56 M
What is Lifecore Biomedical annual revenue year-on-year change?
Over the past year, LFCR annual revenue has changed by +$24.99 M (+24.20%)
What is Lifecore Biomedical quarterly revenue?
The current quarterly revenue of LFCR is $24.70 M
What is the all time high quarterly revenue for Lifecore Biomedical?
Lifecore Biomedical all-time high quarterly revenue is $155.55 M
What is Lifecore Biomedical quarterly revenue year-on-year change?
Over the past year, LFCR quarterly revenue has changed by -$5.45 M (-18.06%)
What is Lifecore Biomedical TTM revenue?
The current TTM revenue of LFCR is $128.44 M
What is the all time high TTM revenue for Lifecore Biomedical?
Lifecore Biomedical all-time high TTM revenue is $589.64 M
What is Lifecore Biomedical TTM revenue year-on-year change?
Over the past year, LFCR TTM revenue has changed by +$16.09 M (+14.32%)